Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) FCF Margin (2019 - 2025)

Historic FCF Margin for Korro Bio (KRRO) over the last 6 years, with Q3 2025 value amounting to 1592.11%.

  • Korro Bio's FCF Margin changed N/A to 1592.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 952.92%, marking a year-over-year change of. This contributed to the annual value of 3433.55% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Korro Bio reported FCF Margin of 1592.11% as of Q3 2025.
  • Korro Bio's FCF Margin's 5-year high stood at 7465.49% during Q1 2023, with a 5-year trough of 1592.11% in Q3 2025.
  • For the 4-year period, Korro Bio's FCF Margin averaged around 343.91%, with its median value being 586.24% (2021).
  • Examining YoY changes over the last 5 years, Korro Bio's FCF Margin showed a top increase of -645800bps in 2021 and a maximum decrease of -4526200bps in 2021.
  • Quarter analysis of 4 years shows Korro Bio's FCF Margin stood at 195.65% in 2021, then skyrocketed by 3916bps to 7465.49% in 2023, then tumbled by -105bps to 393.97% in 2024, then tumbled by -304bps to 1592.11% in 2025.
  • Its FCF Margin stands at 1592.11% for Q3 2025, versus 1326.58% for Q2 2025 and 963.57% for Q1 2025.